EP3727379
CRYSTALLINE MONO-SODIUM SALT OF N-(5-(3-CYANOPYRAZOLO[1,5-A]PYRIDIN-5-YL)2-METHOXYPYRIDIN-3-YL)-2,4-DIFLUORO-BENZENESULFONAMIDE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.12.2018EP published:
22.1.2025EP application number:
18892254.6
EPO information:
European Patent Register
Max expiry date:
14.12.2038
Title in English:
CRYSTALLINE MONO-SODIUM SALT OF N-(5-(3-CYANOPYRAZOLO[1,5-A]PYRIDIN-5-YL)2-METHOXYPYRIDIN-3-YL)-2,4-DIFLUORO-BENZENESULFONAMIDELanguage of the patent:
English
Timeline
Today
15.12.2018EP application
22.1.2025EP Publication
Owner
Name:
Sunshine Lake Pharma Co., Ltd.Address:
Northern Industrial Area Songshan Lake, Dongguan, Guangdong 523000, CN
Inventor
Name:
XI, NingAddress:
Newbury Park, CA 91320, US
Name:
SUN, MingmingAddress:
Dongguan, Guangdong 523871, CN
Priority
Number:
201762608330 PDate:
20.12.2017Country:
US
Classification
Categories:
C07D 471/04, A61K 31/437, A61K 31/444